Catenae Innovation PLC - Newcastle-based digital media technology firm - Renames its 50/50 Joint Venture company with BHA-Medical, to Synovate Global Ltd and Synovate has received its first orders. Providing antibody test kits for UK badminton governing body Badminton England and for sercurity services firm Stone Bailey. Says Badminton England nor the Stone Bailey agreements will generate significant revenues for company.
Chief Executive Officer Guy Meyer says: "We are delighted to officially launch Synovate and to be able to provide commercial organisations with a comprehensive offering that they can use to test and securely manage Covid-19 cases within their corporations. Importantly, Synovate ensures that results from both Antigen and Antibody test are fed into PHE, where, in turn, they are inputted into the NHS's 'Test and Trace' platform. Our platform is able to accept tests results from a range of differing testing procedures and is also able to accept an individual's vaccination information."
Current stock price: 2.42 pence
Year-to-date change: more than double
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.